Share on StockTwits

Stericycle (NASDAQ:SRCL) has been given an average rating of “Buy” by the eleven ratings firms that are presently covering the stock, Analyst Ratings Network.com reports. Four analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $131.45.

SRCL has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Stericycle in a research note on Monday. They now have a $124.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Stericycle in a research note on Friday, July 25th. They now have a $136.00 price target on the stock, up previously from $127.00. Finally, analysts at Robert W. Baird upgraded shares of Stericycle from a “neutral” rating to an “outperform” rating in a research note on Friday, June 13th. They now have a $140.00 price target on the stock, up previously from $128.00. They noted that the move was a valuation call.

In other Stericycle news, CFO Brink Frank Jm Ten sold 45,000 shares of the company’s stock in a transaction dated Tuesday, July 29th. The shares were sold at an average price of $118.84, for a total value of $5,347,800.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of Stericycle (NASDAQ:SRCL) opened at 117.65 on Monday. Stericycle has a one year low of $108.62 and a one year high of $125.43. The stock’s 50-day moving average is $118.4 and its 200-day moving average is $115.5. The company has a market cap of $10.116 billion and a P/E ratio of 32.43.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 24th. The company reported $1.03 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.03. The company had revenue of $640.80 million for the quarter, compared to the consensus estimate of $633.95 million. During the same quarter last year, the company posted $0.93 earnings per share. Stericycle’s revenue was up 21.7% compared to the same quarter last year. Analysts expect that Stericycle will post $4.25 EPS for the current fiscal year.

Stericycle, Inc, is in the business of managing regulated waste and providing an array of related and complementary services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.